Literature DB >> 21102245

MEK/MAPK inhibitors.

Grace Dy1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21102245     DOI: 10.1097/01.JTO.0000391372.94376.37

Source DB:  PubMed          Journal:  J Thorac Oncol        ISSN: 1556-0864            Impact factor:   15.609


× No keyword cloud information.
  2 in total

Review 1.  Extracellular signal-regulated kinases modulate DNA damage response - a contributing factor to using MEK inhibitors in cancer therapy.

Authors:  F Wei; J Yan; D Tang
Journal:  Curr Med Chem       Date:  2011       Impact factor: 4.530

2.  Testis-specific hnRNP is expressed in colorectal cancer cells and accelerates cell growth mediating ZDHHC11 mRNA stabilization.

Authors:  Yuki Murakami; Hiroaki Konishi; Mikihiro Fujiya; Keitaro Takahashi; Katsuyoshi Ando; Nobuhiro Ueno; Shin Kashima; Kentaro Moriichi; Hiroki Tanabe; Toshikatsu Okumura
Journal:  Cancer Med       Date:  2022-04-05       Impact factor: 4.711

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.